Recent Quarter Total Invested
$48.81 B
Recent Quarter Institutional Ownership Percentage
95.66%
Total Invested of Last Quarter
$29.15 B
Ownership Percentage of Last Quarter
94.62%
Alnylam Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CAPITAL WORLD INVESTORS | 11/13/2024 | 16.51 M | $4.54 B | 10.27% | 12.84% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 9.71 M | $2.67 B | 100.00% | 7.55% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 11/13/2024 | 5.24 M | $1.44 B | 61.07% | 4.08% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 4.95 M | $1.36 B | -20.24% | 3.85% |
| BAILLIE GIFFORD & CO | 11/05/2024 | 4.89 M | $1.34 B | -18.99% | 3.80% |
| CAPITAL INTERNATIONAL INVESTORS | 11/13/2024 | 3.97 M | $1.09 B | 2.05% | 3.09% |
| DODGE & COX | 11/13/2024 | 3.62 M | $996.31 M | -4.17% | 2.82% |
| STATE STREET CORP | 11/14/2024 | 3.47 M | $953.89 M | -1.88% | 2.70% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 3.45 M | $949.36 M | -1.04% | 2.68% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 3.14 M | $863.39 M | -0.46% | 2.44% |
| JPMORGAN CHASE & CO | 11/08/2024 | 2.16 M | $594.87 M | 22.00% | 1.68% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 2.15 M | $589.21 M | 3.22% | 1.67% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 1.59 M | $438.05 M | 17.62% | 1.24% |
| GROUPAMA ASSET MANAGMENT | 11/15/2024 | 1.52 M | $6.13 B | 6,177.89% | 1.18% |
| ORBIS ALLAN GRAY LTD | 11/14/2024 | 1.27 M | $348.77 M | 75.87% | 0.99% |
| WINSLOW CAPITAL MANAGEMENT, LLC | 11/13/2024 | 961,607 | $264.47 M | 100.00% | 0.75% |
| LEGAL & GENERAL GROUP PLC | 11/14/2024 | 960,959 | $264.29 M | 3.74% | 0.75% |
| BELLEVUE GROUP AG | 11/14/2024 | 809,095 | $222.53 M | -12.04% | 0.63% |
| INVESCO LTD. | 11/12/2024 | 695,868 | $191.38 M | 77.14% | 0.54% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 664,722 | $182.80 M | -12.37% | 0.52% |
| MORGAN STANLEY | 11/14/2024 | 618,563 | $170.12 M | -16.58% | 0.48% |
| AMUNDI | 11/13/2024 | 593,320 | $160.90 M | -19.53% | 0.46% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 550,772 | $151.48 M | -12.73% | 0.43% |
| LOOMIS SAYLES & CO L P | 11/13/2024 | 525,303 | $144.47 M | -7.73% | 0.41% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 505,654 | $138.95 M | 86.16% | 0.39% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 488,283 | $134.23 M | -0.34% | 0.38% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 487,348 | $134.04 M | 3.56% | 0.38% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 474,439 | $130.48 M | -29.58% | 0.37% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 441,092 | $121.31 M | -25.04% | 0.34% |
| ROYAL BANK OF CANADA | 11/14/2024 | 411,066 | $113.06 M | -0.07% | 0.32% |
| GILDER GAGNON HOWE & CO LLC | 11/14/2024 | 383,993 | $105.61 M | -3.67% | 0.30% |
| FRANKLIN RESOURCES INC | 11/12/2024 | 382,973 | $108.50 M | 32.37% | 0.30% |
| SWISS NATIONAL BANK | 11/07/2024 | 375,400 | $103.25 M | 0.27% | 0.29% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 362,700 | $99.75 M | -60.30% | 0.28% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 356,100 | $97.94 M | -30.81% | 0.28% |
| CANDRIAM S.C.A. | 11/13/2024 | 351,668 | $96.71 M | 0.13% | 0.27% |
| CANADA PENSION PLAN INVESTMENT BOARD | 11/14/2024 | 344,858 | $94.85 M | 21.46% | 0.27% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 332,305 | $91.39 M | 18.94% | 0.26% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 310,000 | $85.26 M | 8.77% | 0.24% |
| EAGLE ASSET MANAGEMENT INC | 11/12/2024 | 309,589 | $85.89 M | 25.74% | 0.24% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 301,389 | $82.89 M | 13.22% | 0.23% |
| FIRST TRUST ADVISORS LP | 11/13/2024 | 285,571 | $78.54 M | 18.72% | 0.22% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 285,100 | $78.41 M | -35.18% | 0.22% |
| ROYAL LONDON ASSET MANAGEMENT LTD | 11/14/2024 | 279,750 | $76.94 M | -0.92% | 0.22% |
| CI PRIVATE WEALTH, LLC | 11/12/2024 | 278,485 | $76.59 M | 1.36% | 0.22% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 11/05/2024 | 278,241 | $76.52 M | 0.47% | 0.22% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 266,497 | $73.29 M | 29.27% | 0.21% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 250,963 | $69.02 M | 81.20% | 0.20% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 250,300 | $68.84 M | 0.00% | 0.19% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 250,000 | $68.76 M | 0.00% | 0.19% |
Alnylam Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ALNY shares?
During the previous two years, 761 institutional investors and hedge funds held shares of Alnylam Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Capital World Investors: 16.51 M
BlackRock Funding, Inc. /DE: 9.71 M
Capital Research Global Investors: 5.24 M
WELLINGTON MANAGEMENT GROUP LLP: 4.95 M
BAILLIE GIFFORD & CO: 4.89 M
Capital International Investors: 3.97 M
-
What percentage of Alnylam Pharmaceuticals, Inc. stock is owned by institutional investors?
95.66% of Alnylam Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at ALNY ?
Institutional investors have bought a total of 116.44 M shares in the last 24 months. This purchase volume represents approximately $28.52 B in transactions.